Scientists claim that the quest for new cancer treatments could be revolutionised by advances in technology that can visualise living cells and tissues.
Significant Breakthrough in Developing New Cancer Drugs
Researchers recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.
Researchers recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.
Researchers at the University of Edinburgh are leading the way in using biological imaging to make the development of new cancer treatments more efficient.
Recent advances mean that scientists can now check how experimental drugs are working inside living cells and in real time.
New Technique Uses ATP Trigger to Deliver Anti-cancer Drugs Directly into Cancer Cells
A new technique that uses adenosine-5'-triphosphate the so-called energy molecule to trigger the release of anti-cancer drugs has been developed by biomedical engineering researchers.
A new technique that uses adenosine-5'-triphosphate the so-called energy molecule to trigger the release of anti-cancer drugs has been developed by biomedical engineering researchers.
This pioneering approach – known as phenotypic drug discovery – monitors the effect of a trial drug on the disease as a whole rather than its impact on an individual target protein, which has been the approach until now.
Advertisements
Research Indicates Several FDA-Approved Anti-Cancer Drugs Induce Stem Cell Tumors
A research team reports that several chemotherapy drugs induce hyper proliferation in stem cells.
A research team reports that several chemotherapy drugs induce hyper proliferation in stem cells.
Currently, just five per cent of drugs tested in clinical trials are approved as therapies for patients. Often drugs do not work in a person as they do in an artificial environment. Sometimes treatments have unexpected side effects that are only picked up in the later stages of the development process.
Advertisements
Roche Urged to Cut Price of Breast Cancer Drugs
Swiss Pharmaceutical giant Roche was urged to cut the cost of a groundbreaking breast cancer drug that Britain's National Health Service is set to phase out in 2016.
Swiss Pharmaceutical giant Roche was urged to cut the cost of a groundbreaking breast cancer drug that Britain's National Health Service is set to phase out in 2016.
Source-Eurekalert
